So our adjusted earnings per share grew to $1.76 in the quarter, up 5% over Q3 '20.
We now expect recurring revenue growth of 8% to 10% and adjusted earnings per share growth of 11% to 13%.
Fast forward nine months, and we are poised to deliver 8% to 10% recurring revenue growth, driven by a combination of strong new sales and healthy financial markets.
As a result of that strong organic growth and an increase in our outlook for the fourth quarter, we're raising our guidance for recurring revenue growth to 8% to 10% for the full year, up from our prior guidance of growth at the higher end of 3% to 6%.
We are raising our outlook for fiscal '21 recurring revenue growth to 8% to 10% from the higher end of 3% to 6%, and that includes one point of growth from Itiviti.
We are raising our guidance for total revenue growth to 8% to 10% from the higher end of 1% to 4%.
We are on track to deliver strong 8% to 10% recurring revenue growth.
We now expect recurring revenue growth of 8% to 10% and adjusted earnings per share growth of 11% to 13%.
And yet even after those investments and the near-term dilution from Itiviti, we're positioned to deliver 11% to 13% adjusted earnings per share growth.
We expect adjusted earnings per share growth of 11% to 13%, up from the higher end of 6% to 10%, and that includes a 1-point drag from Itiviti.
